HOUSTON--Building on a prior relationship, Lark Technologies and the Novartis Research Foundation have negotiated a new agreement. Lark will provide DNA sequencing services to support gene discovery efforts at the institute. Novartis will supply biological materials to Lark, which will offer high-throughput sequencing for an undisclosed fee. Novartis has been a client of Lark for several years, said Doug Wheeler, Lark's president and COO.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.